AI Biotechnology LLC 13D and 13G filings for VYNE Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-11-13 08:24 am Purchase | 2023-11-01 | 13D | VYNE Therapeutics Inc. VYNE | AI Biotechnology LLC | 3,201,980 19.990% | 3,201,980 (New Position) | Filing |